These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 28438397)

  • 1. Endothelial-to-mesenchymal transition: A novel therapeutic target for cardiovascular diseases.
    Jackson AO; Zhang J; Jiang Z; Yin K
    Trends Cardiovasc Med; 2017 Aug; 27(6):383-393. PubMed ID: 28438397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-coding RNA in endothelial-to-mesenchymal transition.
    Hulshoff MS; Del Monte-Nieto G; Kovacic J; Krenning G
    Cardiovasc Res; 2019 Oct; 115(12):1716-1731. PubMed ID: 31504268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial to mesenchymal transition in the cardiovascular system.
    Gong H; Lyu X; Wang Q; Hu M; Zhang X
    Life Sci; 2017 Sep; 184():95-102. PubMed ID: 28716564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The morphological and molecular mechanisms of epithelial/endothelial-to-mesenchymal transition and its involvement in atherosclerosis.
    Wesseling M; Sakkers TR; de Jager SCA; Pasterkamp G; Goumans MJ
    Vascul Pharmacol; 2018 Jul; 106():1-8. PubMed ID: 29471141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial-to-Mesenchymal Transition in Cardiovascular Pathophysiology.
    Singh A; Bhatt KS; Nguyen HC; Frisbee JC; Singh KK
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial to mesenchymal transition in atherosclerotic vascular remodeling.
    Hao YM; Yuan HQ; Ren Z; Qu SL; Liu LS; Dang-HengWei ; Yin K; Fu M; Jiang ZS
    Clin Chim Acta; 2019 Mar; 490():34-38. PubMed ID: 30571947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial-to-mesenchymal transition in cardiovascular diseases: Developmental signaling pathways gone awry.
    Sánchez-Duffhues G; García de Vinuesa A; Ten Dijke P
    Dev Dyn; 2018 Mar; 247(3):492-508. PubMed ID: 28891150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial-to-Mesenchymal Transition: Role in Cardiac Fibrosis.
    Cheng W; Li X; Liu D; Cui C; Wang X
    J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):3-11. PubMed ID: 32851865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A promising field: regulating imbalance of EndMT in cardiovascular diseases.
    Zhou K; Tian KJ; Yan BJ; Gui DD; Luo W; Ren Z; Wei DH; Liu LS; Jiang ZS
    Cell Cycle; 2021 Aug; 20(15):1477-1486. PubMed ID: 34266366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial to Mesenchymal Transition in the Cardiogenesis and Cardiovascular Diseases.
    Anbara T; Sharifi M; Aboutaleb N
    Curr Cardiol Rev; 2020; 16(4):306-314. PubMed ID: 31393254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of endothelial-to-mesenchymal transition in cardiac fibrosis: role of myocardin-related transcription factor A and activating transcription factor 3.
    Sharma V; Dogra N; Saikia UN; Khullar M
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1263-1270. PubMed ID: 28686848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial-mesenchymal transition in atherosclerosis.
    Souilhol C; Harmsen MC; Evans PC; Krenning G
    Cardiovasc Res; 2018 Mar; 114(4):565-577. PubMed ID: 29309526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial-Mesenchymal Transition in Cardiovascular Disease.
    Alvandi Z; Bischoff J
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2357-2369. PubMed ID: 34196216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial-to-mesenchymal transition contributes to fibro-proliferative vascular disease and is modulated by fluid shear stress.
    Moonen JR; Lee ES; Schmidt M; Maleszewska M; Koerts JA; Brouwer LA; van Kooten TG; van Luyn MJ; Zeebregts CJ; Krenning G; Harmsen MC
    Cardiovasc Res; 2015 Dec; 108(3):377-86. PubMed ID: 26084310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future Targets in Endothelial Biology: Endothelial Cell to Mesenchymal Transition.
    Chen PY; Simons M
    Curr Drug Targets; 2016; 17(15):1707-1713. PubMed ID: 27138761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular and Cellular Aspects of the Endothelial-Mesenchymal Transition in Cardiovascular Diseases].
    Strelnikova EA; Kalinin RE; Suchkov IA; Korotkova NV; Mzhavanadze ND
    Mol Biol (Mosk); 2023; 57(4):563-572. PubMed ID: 37528777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases.
    Pardali E; Sanchez-Duffhues G; Gomez-Puerto MC; Ten Dijke P
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of β-catenin prevents EndMT in vitro and vascular remodeling in vivo resulting from endothelial Akt1 suppression.
    Sabbineni H; Verma A; Artham S; Anderson D; Amaka O; Liu F; Narayanan SP; Somanath PR
    Biochem Pharmacol; 2019 Jun; 164():205-215. PubMed ID: 30991049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EMT and EndMT: Emerging Roles in Age-Related Macular Degeneration.
    Shu DY; Butcher E; Saint-Geniez M
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial-to-Mesenchymal Transition: A Potential Mechanism for Atherosclerosis Plaque Progression and Destabilization.
    Li A; Peng W; Xia X; Li R; Wang Y; Wei D
    DNA Cell Biol; 2017 Nov; 36(11):883-891. PubMed ID: 28920704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.